Get started
Author

Yongzeng Wang

Long-Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic Leukemia
2018 · Jae H. Park, Isabelle Rivière, et al. · New England Journal of Medicine · 2,762
PDF
Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia
2014 · Marco L. Davila, Isabelle Riviere, et al. · Science Translational Medicine · 2,537
AtNOS/AtNOA1 Is a Functional Arabidopsis thaliana cGTPase and Not a Nitric-oxide Synthase
2008 · Magali Moreau, Gyu In Lee, et al. · Journal of Biological Chemistry · 315
Preclinical Efficacy and Safety of a Human Embryonic Stem Cell-Derived Midbrain Dopamine Progenitor Product, MSK-DA01
2021 · Jinghua Piao, Susan Zabierowski, et al. · Cell stem cell · 253
PDF
Characterization of Synergy Between Cucumber mosaic virus and Potyviruses in Cucurbit Hosts
2002 · Yongzeng Wang, Victor Gaba, et al. · Phytopathology · 144
PDF
Roles for host factors in plant viral pathogenicity
2004 · Steven A Whitham, Yongzeng Wang · Current Opinion in Plant Biology · 136
Safety and tolerability of conditioning chemotherapy followed by CD19-targeted CAR T cells for relapsed/refractory CLL
2019 · Mark B. Geyer, Isabelle Rivière, et al. · JCI Insight · 101
PDF
Functional analysis of the Cucumber mosaic virus 2b protein: pathogenicity and nuclear localization
2004 · Yongzeng Wang, Tzvi Tzfira, et al. · Journal of General Virology · 94
Engineering zucchini yellow mosaic potyvirus as a non-pathogenic vector for expression of heterologous proteins in cucurbits
2001 · Tzahi Arazi, Shalom Guy Slutsky, et al. · Journal of Biotechnology · 90
CD19 CAR T cells following autologous transplantation in poor-risk relapsed and refractory B-cell non-Hodgkin lymphoma
2019 · Craig S. Sauter, Brigitte Senechal, et al. · Blood · 89
Autologous CD19-Targeted CAR T Cells in Patients with Residual CLL following Initial Purine Analog-Based Therapy
2018 · Mark B. Geyer, Isabelle Rivière, et al. · Molecular Therapy · 76
PDF
Depletion of high-content CD14+ cells from apheresis products is critical for successful transduction and expansion of CAR T cells during large-scale cGMP manufacturing
2021 · Xiuyan Wang, Oriana Borquez-Ojeda, et al. · Molecular Therapy — Methods & Clinical Development · 51
Transgenic cucumbers harboring the 54-kDa putative gene of Cucumber fruit mottle mosaic tobamovirus are highly resistant to viral infection and protect non-transgenic scions from soil infection
2005 · Amit Gal-On, Dalia Wolf, et al. · Transgenic Research · 49
Implications of Minimal Residual Disease Negative Complete Remission (MRD-CR) and Allogeneic Stem Cell Transplant on Safety and Clinical Outcome of CD19-Targeted 19-28z CAR Modified T Cells in Adult Patients with Relapsed, Refractory B-Cell ALL
2015 · Jae H Park, Isabelle Riviere, et al. · Blood · 47
Transgenic Resistance to Cucumber Mosaic Virus in Tomato: Blocking of Long-Distance Movement of the Virus in Lines Harboring a Defective Viral Replicase Gene
1998 · Amit Gal-On, Dalia Wolf, et al. · Phytopathology · 37
PDF
A new approach for weed control in a cucurbit field employing an attenuated potyvirus-vector for herbicide resistance
2001 · Yoel Moshe Shiboleth, Tzahi Arazi, et al. · Journal of Biotechnology · 35
Baseline and early post-treatment clinical and laboratory factors associated with severe neurotoxicity following 19-28z CAR T cells in adult patients with relapsed B-ALL.
2017 · Jae Hong Park, Bianca Santomasso, et al. · Journal of Clinical Oncology · 31
Tobamovirus infection is independent of HSP101 mRNA induction and protein expression
2006 · Tyrell Carr, Yongzeng Wang, et al. · Virus Research · 18
Durable long-term survival of adult patients with relapsed B-ALL after CD19 CAR (19-28z) T-cell therapy.
2017 · Jae Hong Park, Isabelle Riviere, et al. · Journal of Clinical Oncology · 17
Identification of a Novel Plant Virus Promoter using a Potyvirus Infectious Clone
2000 · Yongzeng Wang, Victor Gaba, et al. · Virus Genes · 17
Development and Evaluation of a Human Single Chain Variable Fragment (scFv) Derived Bcma Targeted CAR T Cell Vector Leads to a High Objective Response Rate in Patients with Advanced MM
2017 · Eric L Smith, Sham Mailankody, et al. · Blood · 16
Multi-Center Clinical Trial of CAR T Cells in Pediatric/Young Adult Patients with Relapsed B-Cell ALL
2015 · Kevin J. Curran, Isabelle Riviere, et al. · Blood · 10
Sustained Remission and Decreased Severity of CAR T-Cell Related Adverse Events: A Pivotal Study Report of CNCT19 (inaticabtagene autoleucel) Treatment in Adult Patients with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia (R/R B-Cell ALL) in China
2022 · Ying Wang, Xudong Wei, et al. · Blood · 8
A phase I trial of CD19-targeted EGFRt/19-28z/4-1BBL armored chimeric antigen receptor (CAR) modified T cells in patients with relapsed or refractory chronic lymphocytic leukemia.
2017 · Jae Hong Park, Isabelle Riviere, et al. · Journal of Clinical Oncology · 8
Concurrent therapy of chronic lymphocytic leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia utilizing CD19-targeted CAR T-cells
2017 · Mark B. Geyer, Shwetha H. Manjunath, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 6
Works count: 32
Citation count: 6,957
H-index: 18
I10-index: 22
Year
Topic
Type